scholarly journals How to measure innovation in radiotherapy: an application of the Delphi method

2015 ◽  
Vol 4 (4) ◽  
pp. 14
Author(s):  
Maria Jacobs ◽  
Liesbeth Boersma ◽  
Andre Dekker ◽  
Mark Govers ◽  
Philippe Lambin ◽  
...  

Objective: Innovation is an important driver for improving the quality of health care, yet a tension exists between innovation and providing cost-effective health care. To develop strategies that promote innovation, parameters are needed that are indicative of innovation. However, no recognised indicators of innovation in radiotherapy are currently available. The aim of this study is to fill that gap by providing a framework for measuring innovation. This should facilitate future multi-centric studies on strategies aimed at promoting innovation in radiotherapy.Methods: We applied the Delphi method in four rounds. The chairpersons of all Dutch radiotherapy departments were asked to suggest indicators. The resulting inventory was assessed by a number of Dutch radiation oncologists, medical physicists and managers. After implementig a cut-off score on suitability and measurability, we asked Dutch professors on innovation to assess the remaining indicators. Finally, the chairpersons reached consensus.Results: On the basis of the Delphi study, we derived 13 indicators in four categories, more specific product innovation, technology innovation, market innovation and organisational innovation, for measuring both incremental and radical innovations in radiotherapy; these indicators are also suitable for measuring the generation and adoption of innovations.Conclusions: We were successful in reaching consensus amongst the experts on indicators that measure innovations in radiotherapy. The developed tool will be used to investigate the relation between innovation and possible factors inhibiting or stimulating successful innovation and between the level of innovation and its effects.

2009 ◽  
Vol 15 (5) ◽  
pp. 248-250
Author(s):  
David Rakel ◽  
Stephen Bolles ◽  
Lori Knutson ◽  
Patricia M. Herman ◽  
Douglas Hiza ◽  
...  

1994 ◽  
Vol 19 (2) ◽  
pp. 53-61 ◽  
Author(s):  
Alan H. Rosenstein

2006 ◽  
Vol 22 (2) ◽  
pp. 235-241 ◽  
Author(s):  
Pirjo Räsänen ◽  
Eija Roine ◽  
Harri Sintonen ◽  
Virpi Semberg-Konttinen ◽  
Olli-Pekka Ryynänen ◽  
...  

Objectives: The objectives of this study were to identify, in a systematic literature review, published studies having used quality-adjusted life years (QALYs) based on actual measurements of patients' health-related quality of life (HRQoL) and to determine which HRQoL instruments have been used to calculate QALYs. Furthermore, the aims were to characterize studies with regard to medical specialty, intervention studied, results obtained, quality, country of origin, QALY gain observed, and interpretation of results regarding cost-effectiveness.Methods: Systematic searches of the literature were made using the MEDLINE, Embase, CINAHL, SCI, and Cochrane Library electronic databases. Initial screening of identified articles was based on abstracts read independently by two of the authors; full-text articles were again evaluated by two authors, who made the final decision on which articles should be included.Results: The search identified 3,882 articles; 624 were obtained for closer review. Of the reviewed full-text articles, seventy reported QALYs based on actual before–after measurements using a valid HRQoL instrument. The most frequently used instrument was EuroQol HRQoL instrument (EQ-5D, 47.5 percent). Other instruments used were Health Utilities Index (HUI, 8.8 percent), the Rosser–Kind Index (6.3 percent), Quality of Well-Being (QWB, 6.3 percent), Short Form-6D (SF-6D, 5.0 percent), and 15D (2.5 percent). The rest (23.8 percent) used a direct valuation method: Time Trade-Off (10.0 percent), Standard Gamble (5.0 percent), visual analogue scale (5.0 percent), or rating scale (3.8 percent). The most frequently studied medical specialties were orthopedics (15.5 percent), pulmonary diseases (12.7 percent), and cardiology (9.9 percent). Ninety percent of the studies came from four countries: United Kingdom, United States, Canada, the Netherlands. Approximately half of the papers were methodologically high quality randomized trials. Forty-nine percent of the studied interventions were viewed by the authors of the original studies as being cost-effective; only 13 percent of interventions were deemed not to be cost-effective.Conclusions: Although QALYs gained are considered an important measure of effectiveness of health care, the number of studies in which QALYs are based on actual measurements of patients' HRQoL is still fairly limited.


1991 ◽  
Vol 213 (5) ◽  
pp. 433-439 ◽  
Author(s):  
WILLIAM H. EDWARDS ◽  
JOHN A. MORRIS ◽  
JUDITH M. JENKINS ◽  
SUE M. BASS ◽  
ELLEN J. MACKENZIE

Communication and technology in a health care setting is the most important tool in health promotion. Recently, cloud computing technology is used to enable cost-effective applications to facilitate communication, information sharing and record maintenance regarding health and medicine. It allows dissemination of information from facebook, which is currently the largest online social network. Combining cloud computing and social networking could allow creating health social networking system employing a human –oriented, interactive medical web and this would improve the quality of current applications in health care communication and technology.


1994 ◽  
Vol 9 (2) ◽  
pp. 140-141 ◽  
Author(s):  

The proliferation of air medical transport in the 1980s and 1990s has been accompanied by minimal investigation into the appropriateness of transport. A strong foundation has been developed regarding adult trauma. However, important issues in pediatric and general medical patients have not been addressed. The health care crisis in America mandates air medical transport systems to provide appropriate access to medical technology and resources in a cost-effective manner while maintaining quality of care. We must identify the patients whose outcomes will benefit from air medical transport.


Science ◽  
1976 ◽  
Vol 192 (4240) ◽  
pp. 619-619 ◽  
Author(s):  
P. H. ABELSON

2000 ◽  
Vol 20 (1) ◽  
pp. 7-12 ◽  
Author(s):  
Philip A. McFarlane ◽  
David C. Mendelssohn

Epidemic growth rates and the enormous cost of dialysis pressure end-stage renal disease (ESRD) delivery systems around the world. Payers of dialysis services can constrain costs through ( 1 ) limiting access to dialysis, ( 2 ) reducing the quality of dialysis, and ( 3 ) placing constraints on modality distribution. In order to secure the necessary resources for ESRD care, we propose that the nephrology community consider the following suggestions: First, future leaders in dialysis should acquire additional advanced training in innovative pathways such as health care economics, business and health care administration, and health care policy. Second, the international nephrology community must strongly engage in ongoing advocacy for accessible, high quality, cost-effective care. Third, efforts should be made to better define and then implement optimal dialysis modality distributions that maximize patient outcomes but limit unnecessary costs. Fourth, industry should be encouraged to lower the unit cost of dialysis, allowing for improved access to dialysis, especially in developing countries. Fifth, research should be encouraged that seeks to identify measures that will reduce dialysis costs but will not impair quality of care. Finally, early referral of patients with progressive renal disease to nephrology clinics, empowerment of informed patient choice of dialysis modality, and proper and timely access creation should be encouraged and can be expected to help limit overall expenditures. Ongoing efforts in these areas by the nephrology community will be essential if we are to overcome the challenges of ESRD growth in this new decade.


Sign in / Sign up

Export Citation Format

Share Document